Deferoxamine Mesylate Injection, Powder, Lyophilized, For Solution
Product Images NDC 68083-172

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Deferoxamine Mesylate (NDC 68083-172). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gland Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Deferoxamine-spl-structure (Deferoxamine Spl Structure)

Chemical structure of deferoxamine mesylate showing multiple amide and hydroxyl functional groups connected by carbon chains with sulfonic acid group indicated.*

FDA Label Image

Deferoxamine-spl-500mg-vial.jpg (Deferoxamine Spl 500mg Vial)

Label for Deferoxamine Mesylate for Injection, USP 500 mg per vial, a lyophilized powder for injection intended for subcutaneous, intramuscular, or intravenous use. The label states single-dose use only and provides storage instructions between 20° to 25°C. Manufactured by Gland Pharma Limited in Hyderabad, India, the label includes barcode areas and space for batch and expiration details.*

FDA Label Image

Deferoxamine-spl-500mg-carton.jpg (Deferoxamine Spl 500mg Carton)

Packaging label for Deferoxamine Mesylate for Injection, USP 500 mg per vial, lyophilized powder for solution by Gland Pharma Limited. The label is designed for a 4-vial pack, indicating subcutaneous, intramuscular, or intravenous administration. Includes storage instructions, dosage warnings, and a barcode.*

FDA Label Image

Deferoxamine-spl-2g-vial.jpg (Deferoxamine Spl 2g Vial)

Label for Deferoxamine Mesylate for Injection, USP showing 2 g per vial strength. The lyophilized powder is indicated for subcutaneous, intramuscular, or intravenous use and labeled for single-dose only. Manufactured by Gland Pharma Limited, India. The label provides storage instructions, usage warnings, and includes a barcode.*

FDA Label Image

Deferoxamine-spl-2g-carton.jpg (Deferoxamine Spl 2g Carton)

Packaging label for Deferoxamine Mesylate for Injection, USP, 2 g per vial, lyophilized powder for solution. The label indicates use via subcutaneous, intramuscular, or intravenous routes. Each vial contains 2 g deferoxamine mesylate USP, single-dose only, with 4 vials per package. Manufactured by Gland Pharma Limited, the label includes storage instructions and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.